A nationwide supplement recall: the capsules had hidden sildenafil and acetaminophen

Capsules sold as a male sexual enhancement product have been pulled from the market because they contain two drugs the label never mentioned. Game Changer Products LLC of Tampa, Florida, announced a voluntary nationwide recall of its 10 Day Forecast Capsules 3200mg on Nov. 12, after testing found undeclared sildenafil and acetaminophen. All lots are included.

Read next on Morning Overview: A $1 billion gas plant planned for Superior, Wisconsin, has been abandoned

Two drugs the label left out

Sildenafil is the active ingredient in the prescription erectile dysfunction drug Viagra, and acetaminophen is the common over-the-counter pain and fever reliever. Neither appears as an ingredient on the product, which is why the FDA treats it as a tainted supplement rather than a mislabeled one: a buyer picking up a “natural” capsule has no way to know a prescription-strength drug is inside.

The company’s own recall notice, posted on the FDA’s recall page as a nationwide recall, describes the capsules as tainted with sildenafil and acetaminophen. According to the ConsumerLab report on the recall, the product comes on cards holding one or two blue capsules, in packaging with a black background and white lettering, under UPC 191645852717.

Why a hidden sildenafil dose is dangerous with nitrates

Sildenafil combined with nitrates, such as the nitroglycerin that cardiologists prescribe for chest pain, can cause a dangerous fall in blood pressure. The people most likely to be on nitrates are older men with heart disease, which is also a group likely to shop for a sexual enhancement product.

A person who knowingly takes Viagra is supposed to be screened by a prescriber for exactly that interaction. A person who takes a supplement has no such conversation, and the missing label means a doctor reviewing a medication list after an emergency would not know to ask.

Because the amount of sildenafil in the capsules was not disclosed, there is also no dose to reason from. The recall notice treats the presence of the drug itself as the problem, whatever the quantity.

The 3200mg figure on the packaging describes the weight of the capsule contents, not a dose of any drug, and it says nothing about how much sildenafil sits in one capsule. That gap is typical of products that are marketed as supplements but behave like unapproved drugs, because nothing on the card lets a buyer or a pharmacist work out how much of an active ingredient a single capsule delivers.

Acetaminophen and the liver

The second hidden ingredient is quieter but not harmless. Undeclared acetaminophen can stack on top of the acetaminophen a person already takes for a headache or a cold, raising the risk of serious liver injury, liver failure or death. Many cold and flu products contain it, so a user could pass the safe daily ceiling without ever having intended to take more than the labels on the other products allowed.

The recall pages reviewed for this article do not report any specific illness or adverse event tied to the capsules. The action is a precaution grounded in what testing found inside them. GeneOnline’s write-up and NewsNation’s recall item both carry the same two-drug finding, and a separate Medical Daily report shows the pattern of hidden erectile dysfunction drugs recurring across other recalled products in the same period.

Where it was sold and what owners are told to do

Sales ran nationwide, including Puerto Rico, Guam and the Northern Mariana Islands, from at least October 2021 through Oct. 17, 2026, a window of five years. ConsumerLab’s summary lists three channels: the company website, eBay, and one retail store in Minnesota. The recall notice itself lists lot numbers and expiration dates, which ConsumerLab pointed readers to the FDA page for rather than reproducing.

Consumers who still have the capsules are told to stop using them and discard unused product safely. Anyone who has had a possible related problem, such as dizziness after taking them or unusual symptoms alongside nitrate medication, is advised to contact a health care provider. Problems can also be reported through the FDA’s Safety Reporting Portal, a route the ConsumerLab page itself points to.

The timeline is short once the notice is set against the sales window. Sales continued until Oct. 17, 2026, and the company announced the recall on Nov. 12, 26 days later. Anyone who bought a card of capsules on eBay in the autumn of 2026 may still have unopened product, and the one Minnesota store that carried the capsules is a reminder that retail shelves, not only websites, can hold a recalled lot.

Retailers and online sellers are the final checkpoint. A pharmacist or store clerk cannot identify a capsule from its blue color alone, so the packaging details in the notice, the black card with white lettering and the UPC, are the practical way to confirm a match. Anyone who gave the capsules to a partner or friend should pass the warning along, since the risks fall on whoever swallows them, not only on the original buyer.

The picture of how the drugs reached the product is still incomplete. The notice as reported does not say who made the capsules or what batch testing found the drugs, and no company contact is given in the coverage reviewed. Sales through eBay and a single store suggest a small distribution footprint, but the recall remains nationwide because the product went to buyers across the country by mail.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.